Skip to main content
  • English
  • Español
Oryzon
  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
      • Share Performance
      • Shares and Capital Structure
      • Dividends
      • Share Issues
      • Takeover Bids
      • Shareholdings
    • Financial Information
      • Financial Results and Accounts
      • Public Periodic Information
      • Average supplier payment period
    • CNMV Filings
    • Analyst Coverage
    • Corporate Governance
      • General Shareholders Meeting
      • Board of Directors
      • Board Committees
      • Shareholder Agreements
      • Annual Corporate Governance Reports
      • Annual Director Remuneration Reports
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us

News & Events

Breadcrumb

  1. Home
  2. News & Events
  3. Events

Events

  • 28 June 2021

    Annual General Shareholders Meeting 2021

  • 24-25 June 2021

    Spring European Virtual MidCap Event

  • 23 June 2021

    NewYorkBIO and NYSE’s Emerging Biotech Company Showcase

  • 14-18 June 2021

    BIO International Convention 2021

  • 10-13 June 2021

    European Hematology Association (EHA) 2021 Congress

  • 8-9 June 2021

    Precision in Drug Discovery & Preclinical Virtual Summit

  • 1-4 June 2021

    Jefferies Virtual Healthcare Conference 2021

  • 1-4 June 2021

    Oxford Global’s Online Drug Discovery Week

  • 25-27 May 2021

    Foro Medcap BME 2021

  • 17-19 May 2021

    BioEquity Europe Digital

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 15
  • Page 16
  • Current page 17
  • Page 18
  • Page 19
  • Page 20
  • Next page Next ›
  • Last page Last »

Email alerts

Subscribe and stay up to date with our latest events

Subscribe
Oryzon Extraordinary General Meeting of Shareholders, 15 December 2026Oryzon Extraordinary General Meeting of Shareholders, 15 December 2026
Logo Oryzon
  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
    • Financial Information
    • CNMV Filings
    • Analyst Coverage
    • Corporate Governance
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us
  • © Oryzon Genomics, S.A. - All Rights Reserved

    • Legal
    • Privacy Policy
    • Cookie Policy
    • Ethics Channel